Comments on: NPI-0052 Shows Promise In Relapsed/Refractory Multiple Myeloma (ASH 2009) http://www.myelomabeacon.com/news/2009/12/28/npi-0052-shows-promise-in-treating-relapsedrefractory-multiple-myeloma-ash-2009/ Multiple myeloma news, resources, and online forums for patients, caregivers, and others interested in multiple myeloma. Sat, 11 Feb 2012 15:20:52 +0000 hourly 1 By: Funmi Adewale http://www.myelomabeacon.com/news/2009/12/28/npi-0052-shows-promise-in-treating-relapsedrefractory-multiple-myeloma-ash-2009/comment-page-1/#comment-5650 Funmi Adewale Thu, 08 Apr 2010 00:02:05 +0000 http://www.myelomabeacon.com/?p=8934#comment-5650 Hi Jelle, You can find information about NPI-0052 trials by searching “<a href="http://clinicaltrial.gov/ct2/results?term=NPI-0052&recr=&rslt=&type=&cond=multiple+myeloma&intr=&outc=&lead=&spons=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv_s=&rcv_e=&lup_s=&lup_e=" rel="nofollow">NPI-0052 multiple myeloma</a>” at clinicaltrials.gov. Right now, the site does not list any ongoing phase 2 trials. If you are interested in more information about NPI-0052, you can contact Nereus Pharmaceuticals’ Research and Development department directly at <a href="mailto:" rel="nofollow">randd@nereuspharm.com</a>. Hi Jelle,
You can find information about NPI-0052 trials by searching “NPI-0052 multiple myeloma” at clinicaltrials.gov. Right now, the site does not list any ongoing phase 2 trials. If you are interested in more information about NPI-0052, you can contact Nereus Pharmaceuticals’ Research and Development department directly at randd@nereuspharm.com.

]]> By: Jelle PALSMA http://www.myelomabeacon.com/news/2009/12/28/npi-0052-shows-promise-in-treating-relapsedrefractory-multiple-myeloma-ash-2009/comment-page-1/#comment-5638 Jelle PALSMA Wed, 07 Apr 2010 16:08:42 +0000 http://www.myelomabeacon.com/?p=8934#comment-5638 Hello, When will the 2nd phase start for the NPI-0052 MM-trial? I'm very interested in participating in the trial. Where can I get information about this? Hello,

When will the 2nd phase start for the NPI-0052 MM-trial?
I’m very interested in participating in the trial.
Where can I get information about this?

]]> By: Funmi Adewale http://www.myelomabeacon.com/news/2009/12/28/npi-0052-shows-promise-in-treating-relapsedrefractory-multiple-myeloma-ash-2009/comment-page-1/#comment-2248 Funmi Adewale Tue, 12 Jan 2010 01:15:27 +0000 http://www.myelomabeacon.com/?p=8934#comment-2248 Hi Swati, Although the article focuses on NPI-0052 as it relates to multiple myeloma, the compound is being tested in other cancers. <a href="http://www.clinicaltrials.gov/ct2/results?term=npi-0052" rel="nofollow">Clinical trials</a> evaluating NPI-0052’s effectiveness in solid tumors, lymphomas, leukemias, pancreatic cancer, melanoma, and non-small cell lung cancer are currently underway. For more information on the drug, please visit the <a href="http://www.nereuspharm.com/NPI-0052.shtml" rel="nofollow">Nereus Pharmaceuticals</a> Web site. Hi Swati,

Although the article focuses on NPI-0052 as it relates to multiple myeloma, the compound is being tested in other cancers. Clinical trials evaluating NPI-0052’s effectiveness in solid tumors, lymphomas, leukemias, pancreatic cancer, melanoma, and non-small cell lung cancer are currently underway. For more information on the drug, please visit the Nereus Pharmaceuticals Web site.

]]> By: swati chauhan http://www.myelomabeacon.com/news/2009/12/28/npi-0052-shows-promise-in-treating-relapsedrefractory-multiple-myeloma-ash-2009/comment-page-1/#comment-2218 swati chauhan Sun, 10 Jan 2010 09:49:55 +0000 http://www.myelomabeacon.com/?p=8934#comment-2218 why npi-0052 is only used against multiple myeloma and nt against ither types of cancers why npi-0052 is only used against multiple myeloma and nt against ither types of cancers

]]>